ANI Pharmaceuticals, Inc.

Through groundbreaking technology and a relentless commitment to patient care, we are revolutionizing the pharmaceutical landscape at ANI Pharmaceuticals. Our mission, 'Serving Patients, Improving Lives,' drives every aspect of our operations, from our state-of-the-art U.S.-based manufacturing facilities to our strategic focus on rare diseases. We are not just a pharmaceutical company; we are a beacon of hope for patients with unmet medical needs, leveraging our deep expertise in developing and commercializing high-quality branded and generic prescription products. We pride ourselves on our ability to identify and deliver value through strategic acquisitions and internal development, ensuring that our portfolio remains robust and responsive to the evolving needs of the healthcare community.

At the heart of our innovation is our Rare Disease business, where we are making significant strides with novel therapies like Purified Cortrophin® Gel. Our dedicated teams work tirelessly to unlock new possibilities in ophthalmology, rheumatology, nephrology, and neurology, ensuring that life-changing treatments reach those who need them most. We are redefining the standard of care by combining scientific rigor with a compassionate approach to patient support. Furthermore, our robust Generics business and Established Brands portfolio demonstrate our ability to combine operational excellence with strategic foresight, ensuring a steady supply of critical medications. By integrating advanced manufacturing capabilities with a forward-thinking research and development strategy, ANI Pharmaceuticals stands at the forefront of the industry. We are continuously pushing the boundaries of what is possible in healthcare to deliver sustainable growth and, most importantly, a healthier future for patients worldwide.